GlassScriptPhysician profile
Andrew Rahaman
NPI 1992190664
$718.90
in general payments reported to CMS, 2019-2025
13 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $250 · 2021: $69.79 · 2022: $95.31 · 2023: $17.07 · 2024: $56.90 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.71 | 2019-2024 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $112.15 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $55.03 | 2021-2025 | Breztri |
| Amgen INC. | $45.02 | 2020-2025 | Otezla, Repatha |
| Lilly USA, LLC | $41.69 | 2019-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $37.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.22 | 2024 | Jardiance |
| Stryker Corporation | $27.44 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $18.28 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.07 | 2023 | |
| Glaxosmithkline, LLC. | $14.67 | 2022 | |
| Exact Sciences Corporation | $13.86 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rahaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.